Flow Neuroscience
FDA-approved at-home brain stimulation treatment for depression
Malmö, Sweden · Founded 2016 · $23.8M raised
- Headquarters
- Malmö
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2C
- Website
- flowneuroscience.com
- Total Funding
- $23.8M
- Last Round
- $13.0M Venture RoundOct 2025
- Rounds
- 3
About
Flow Neuroscience develops the world's first FDA-approved at-home tDCS (transcranial direct current stimulation) treatment for Major Depressive Disorder. The Flow FL-100 headset is a non-invasive neuromodulation device used in combination with a behavioral therapy app, providing home-based treatment for patients with moderate to severe MDD. Backed by real-world evidence from over 40,000 users and multiple clinical trials, Flow has received medical certification across Europe and the UK, and FDA approval in the US.
Summary
Flow Neuroscience is a Medical Devices company based in Malmö, Sweden, founded in 2016. It has raised $23.8M in total across 3 rounds, most recently a $13.0M Venture Round round in Oct 2025. Investors include Khosla Ventures and Kirin Holdings.
Tech & App Stack
15 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies

Fusion energy company developing clean energy solutions.

operates in the healthcare industry focusing on biotechnology business

Vicarious Surgical improves the lives of patients and surgeons by giving access to high quality c...

Clinical-stage medical technology company developing neural-engineering implants and platforms to...
Digital tools for healthcare providers
Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 D...
